Skip to main content
. 2024 Jul 23;12:1413248. doi: 10.3389/fcell.2024.1413248

FIGURE 5.

FIGURE 5

MeCP2 is a global guardian of the chromatin architecture and epigenome integrity. MeCP2 dosage may lead to different outcomes for epigenome integrity. Binding of MeCP2 to 5-mC may hinder TET activity and oxidation of 5-mC. At reduced levels of MeCP2, dysregulated modulation of the epigenome may permit promiscuous DNMT/TET activity at regions typically regulated by MeCP2 binding. On the contrary, increases levels of MeCP2 may disproportionately hinder DNMT/TET activity in the epigenome. Figure is adapted from Rastegar and Davie 2023 (Rastegar and Davie, 2023). Illustration created in BioRender.com.